文献速递肾癌与肾肿瘤

左侧肾肿瘤伴腔静脉癌栓手术风险更高:多中心研究

Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK).
PubMed 文献 · BJU Int · 2025-04-14

该多中心回顾性研究比较了左侧与右侧肾肿瘤伴腔静脉癌栓行肾切除术的结局,发现左侧组手术时间更长、出血更多、并发症更高,术后肾功能更差且透析率更高,但总生存与无复发生存无差异。

要点

  • 左侧肾肿瘤伴腔静脉癌栓患者术后并发症和需透析的急性肾损伤风险更高。
  • 左侧组手术时间、出血量及输血率均显著高于右侧组。
  • 尽管围手术期风险更高,两组总生存和无复发生存相似。

核心结论

  • 左侧肾肿瘤伴腔静脉癌栓行肾切除术的并发症和需透析的急性肾损伤风险高于右侧。

研究设计与样本

  • 回顾性多中心分析(2008年6月至2023年2月),纳入左侧(n=70)与右侧(n=118)肾肿瘤伴腔静脉癌栓行肾切除术的患者。

主要发现

  • 左侧组手术时间240 vs 193分钟(P<0.001),出血量1700 vs 1000 mL(P=0.042),并发症发生率53% vs 35%(P=0.015)。
  • 左侧组术后即刻eGFR更低(P=0.035),透析率17% vs 6.8%(P=0.026)。
  • 两组总生存(P=0.8)和无复发生存(P=0.43)无显著差异。

临床怎么用

  • 左侧肾肿瘤伴腔静脉癌栓术前应充分规划,术中限制阻断时间以降低并发症和急性肾损伤风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare outcomes of nephrectomy for left-sided (n = 70) vs right-sided (n = 118) renal tumours with caval thrombi. METHODS: In this retrospective analysis (June 2008-February 2023), we evaluated peri-operative variables, 30-day complications, estimated glomerular filtration rate (eGFR), and survival rates. RESULTS: Patients in the left-sided renal tumour group experienced significantly longer operating times (240 vs 193 min; P < 0.001), greater blood loss (1700 vs 1000 mL, P = 0.042), and more complications (53% vs 35%, P = 0.015). Postoperative renal function was worse in the left-sided vs the right-sided renal tumour group, with lower immediate postoperative eGFR (P = 0.035) and a higher dialysis rate (17% vs 6.8%, P = 0.026). However, overall survival and recurrence-free survival were similar (P = 0.8 and P = 0.43, respectively). CONCLUSIONS: Left-sided renal tumours with caval thrombi present a higher risk of complications and acute kidney injury requiring dialysis, potentially due to left renal vein ischaemia during surgery and anatomical proximity to the superior mesenteric artery. Thorough preoperative planning and limited clamping time are essential.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Panis A, Waeckel T, Bensalah K, et al. Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK). BJU Int. 2025. PMID: 40229929. doi:10.1111/bju.16739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。